Colossal Biosciences Bags $200M to Revive Woolly Mammoths at a Digiextinctive $10.2B Valuation!
Colossal Biosciences has raised a staggering $200M in Series C funding to resurrect the woolly mammoth using cutting-edge de-extinction technology, edging its valuation to $10.2B. By blending genome mapping and CRISPR gene-editing, the company aims to restore extinct species while spinning off transformative technologies. What does this mean for the future of biodiversity and biotech?
Jan 17